Insider · CIK 0001738374

Chell Jeffrey W.

Reports to the SEC for 1 company · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001738374

Forms 4 and 5

Insider transactions

15 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-02	ATNMActinium Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+92.4K sh	—	—	92,400
2026-09-02	ATNMActinium Pharmaceuticals, Inc.A Award	Director	AAward	+61.6K sh	—	—	61,600
2025-03-31	ATNMActinium Pharmaceuticals, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−72.2K sh	—	—	0
2025-03-31	ATNMActinium Pharmaceuticals, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,500 sh	—	—	0
2025-03-31	ATNMActinium Pharmaceuticals, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,500 sh	—	—	0
2025-03-31	ATNMActinium Pharmaceuticals, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,333 sh	—	—	0
2025-03-31	ATNMActinium Pharmaceuticals, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−18.4K sh	—	—	0
2025-03-31	ATNMActinium Pharmaceuticals, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,333 sh	—	—	0
2025-03-31	ATNMActinium Pharmaceuticals, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−70.3K sh	—	—	0
2023-12-28	ATNMActinium Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+70.3K sh	—	—	70,311
2022-07-01	ATNMActinium Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+72.2K sh	—	—	72,156
2021-09-01	ATNMActinium Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+18.4K sh	—	—	18,351
2020-08-12	ATNMActinium Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+8,333 sh	—	—	8,333
2019-07-12	ATNMActinium Pharmaceuticals, Inc. · Options to purchase common stockA Award	Director	AAward	+250K sh	$0.23	+$58K	250,000
2018-07-13	ATNMActinium Pharmaceuticals, Inc. · Options to purchase common stockA Award	Director	AAward	+75K sh	$0.78	+$58.7K	75,000

Recent filings

Accepted (ET)
Sep 44
Chell Jeffrey W.0001213900-26-097739
SEC(opens sec.gov)
Apr 24
Chell Jeffrey W.0001213900-25-028231
SEC(opens sec.gov)
Dec 294
Chell Jeffrey W.0001213900-23-100057
SEC(opens sec.gov)
Jul 14
Chell Jeffrey W.0001213900-22-036866
SEC(opens sec.gov)
Sep 34
Chell Jeffrey W.0001213900-21-046688
SEC(opens sec.gov)
Aug 144
Chell Jeffrey W.0001213900-20-022339
SEC(opens sec.gov)
Jul 164
Chell Jeffrey W.0001213900-19-012888
SEC(opens sec.gov)
Jul 174
Chell Jeffrey W.0001213900-18-009325
SEC(opens sec.gov)

Companies

Actinium Pharmaceuticals, Inc.DirectorATNM

Address

C/O ACTINIUM PHARMACEUTICALS, INC. 100 PARK AVE., 23RD FLOOR

NEW YORK, NY, 10017